FOXO FOXO Technologies Inc.: Company Aggregate Indebtedness

FOXO Technologies (FOXO) is integrating AI into epigenetics to analyze DNA markers and determine biological age, establishing a foundation for customized insurance. The company's price evolution reflects the dynamics of a specific debt, which is currently fixed at 0.00. However, the business suffers from a lack of profitability and the threat of delisting, relying on external investments. Meanwhile, the digital nature of its services in the US completely eliminates the impact of global trade conflicts.

This indicator measures the ratio of total liabilities to the market value of the business, determining the extent of the company's dependence on external financing amid Fed rate volatility. By analyzing debt capital, investors assess the ability of FOXO Technologies (FOXO) to maintain autonomous AI analysis of epigenetic markers without the risk of a liquidity gap, which is critical when scaling high-tech longevity calculation algorithms.